Insights
From stratospheric antennas to implantable bio-sensors, from the thermodynamics of carbon capture to quantum technology and AI-designed biology, we use deep tech to challenge and change the status quo.
Read our latest research and insights to help you see beyond the innovation hype and find out how emerging technologies are solving important business problems.
Digital service innovation for quantum cloud computing
What is quantum computing? That’s a question still being asked by much of the world’s C-suite. But here at CC our multidisciplinary teams of physicists, engineers and designers are already helping to plot a credible pathway for a future powered ...
Quantum computing for pharma and life sciences
What can quantum computing and quantum technology do for the pharma and life sciences industry? Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and shares her insights into how organisations can start implementing an action plan ...
Genomics, panomics and long read sequencing for better patient care
Symon Cotton has been reflecting on the future of the genomics ecosystem. Here he discusses how genomics – plus the emergence of panomics and long read sequencing – could inform clinical practice and patient care ...
Desirability, Viability, Feasibility
Not everyone knows how to embark on the road to a new market breakthrough – or has the confidence to overcome natural hesitancy. At CC, we believe in the design thinking approach known as DVF (Desirability, Viability, Feasibility) ...
Quantum sensing technology for the life sciences
Swiss company Qnami, a leader in quantum sensing technology, tasked us with identifying potential applications in the biomedical area where NV magnetometry could provide clinical value and open new commercial avenues ...
What next for precision medicine?
The world of DNA testing is changing fast and the race is on to provide cheap, quick genetic diagnoses for patients. Symon Cotton, Head of Life Sciences takes a look at the opportunities on offer for companies working in this ...
‘Cell mechanomics’ for drug discoveries, cell therapies and precision cancer medicine
Cell4D is developing ‘fingerprinting’ technology for live cells using mechanomics, a discipline sitting at the intersection of biology and biomechanics. This biomarker that is used to screen and sort live cells for cell therapies ...
Collaboration can unlock a successful connected future for global pharma
Global pharma is hitting a major fork in the road, and one way leads to failure. For me, it’s vital that the industry comes together to grasp the once-in-a-generation opportunity that emergent technology is offering ...
Start-up technology risk management in The Engine venture ecosystem
Founders of early-stage start-ups are passionate, driven and optimistic. So, as they embark on the mission to sell their vision, they should accentuate the positive and keep negative thoughts of risk to the back of their mind, right? Wrong ...
